Validation and R&D for a process to manufacture and store autologous iPS cells from long-term-stored umbilical cord blood, with a view to future clinical applications. A theme examining the manufacture of patient-specific autologous iPS cells and their clinical application as an integrated process, while leveraging the storage infrastructure of cord blood banks.